Prevention of infection in children and adolescents with primary immunodeficiency disorders

Asian Pacific Journal of Allergy and Immunology

Volumn 30, Issue 4, 2012, Pages 249-258

  Papadopoulou Alataki, Efimia ^a   Hassan, Amel ^b   Graham Davies, E ^b  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Adolescents; Antimicrobial prophylaxis; Bronchiectasis; Children; Immunizations; Primary immunodeficiencies

Indexed keywords

ACICLOVIR; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BACTERIAL VACCINE; BCG VACCINE; CD4 ANTIGEN; CIPROFLOXACIN; COTRIMOXAZOLE; DAPSONE; FLUCLOXACILLIN; FLUCONAZOLE; GAMMA INTERFERON RECEPTOR 1; IMMUNOGLOBULIN; INFLUENZA VACCINE; INTERLEUKIN 2; ISONIAZID; ITRACONAZOLE; LIVE VACCINE; ORAL POLIOMYELITIS VACCINE; PALIVIZUMAB; PENICILLIN DERIVATIVE; PENTAMIDINE ISETHIONATE; QUINOLONE; RIFAMPICIN; STAT3 PROTEIN; TOBRAMYCIN; WART VIRUS VACCINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBODY PRODUCTION; ANTIBODY TITER; ATAXIA TELANGIECTASIA; BRONCHIECTASIS; CHRONIC GRANULOMATOUS DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; COMPLEMENT DEFICIENCY; DIGEORGE SYNDROME; DISEASE PREDISPOSITION; HERPES VIRUS INFECTION; HUMAN; HYPER IGE SYNDROME; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN DEFICIENCY; INFECTION; LEUKOCYTE ADHESION DEFICIENCY; LOADING DRUG DOSE; LOW DRUG DOSE; MUCOCUTANEOUS CANDIDIASIS; PHAGOCYTE DYSFUNCTION; PNEUMOCYSTIS PNEUMONIA; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SINGLE DRUG DOSE; WISKOTT ALDRICH SYNDROME; X LINKED AGAMMAGLOBULINEMIA;

ADOLESCENT; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFECTION; INFECTION CONTROL; MALE; VACCINATION;

EID: 84873295796     PISSN: 0125877X     EISSN: 22288694     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Kumar A, Teuber SS, Gershwin ME. Current perspectives on primary immunodeficiency diseases. Clin Devel Immunol. 2006;13:223-59.
2. Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, et al. Primary immunodeficiency diseases: An update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120:776-94.
3. Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, et al. Primary B Cell Immunodeficiencies: Comparisons and Contrasts. Annu Rev Immunol. 2009; 27:199-227.
4. Marodi L, Notarangelo LD. Immunological and genetic bases of new primary immunodeficiencies. Nat Rev Immunol. 2007;7:851-61.
5. Casanova JL, Fieschi C, Zhang SY, Abel L. Revisiting human primary immunodeficiencies. J Intern Med. 2008;264:115-27.
6. Ballow M, Notarangelo L, Grimbacher B, Cunningham-Rundles C, Stein M, Helbert M, et al. Immunodeficiencies. Clin Exp Immunol. 2009; 158(S1): 14-22.
7. Davies E.G and Thrasher AJ. Update on the hyper immunoglobulin M syndromes. Brit J Haematol. 2010;149:167-80.
8. Yong PL, Boyle J, Ballow M, Boyle M, Berger M, Bleesing J, et al. Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies. A working group report of a study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology. Clin Immunol. 2010;135:255-63.
9. Tarzi MD, Grigoriadou S, Carr SB, Kuitert LM, Longhurst HJ. Clinical Immunology Review Series: An approach to the management of pulmonary disease in primary antibody deficiency. Clin Exp Immunol. 2008;155:147-55.
10. Freeman AF, Holland SM. Antimicrobial prophylaxis for primary immunodeficiencies. Curr Opin Allergy Clin Immunol. 2009;9:525-30.
11. Glocker E, Ehl S, Grimbacher B. Common variable immunodeficiency in children. Curr Opin Pediatr. 2007;19:685-92.
12. American Academy of Pediatrics. Non group A or B Streptococcal and Enterococcal Infection. In: Pickering LK, Baker CJ, Long SS, McMilan JA, eds. Red Book 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:634-6.
13. Hambleton S, Cant AJ. Advances in the management of primary immunodeficiency. Pediatr Child Health. 2008;18:502-7.
14. Bayraksi B, Ersoy F, Sanal O, Kilic S, Metin A, Tezcan I. The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID). Turkish J Pediatr. 2005;47:239-46.
15. Resch B, Manzoni P, Lanari M. Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syn dromes. Paediatric Respir Rev. 2009;10:148-53.
16. American Academy of Pediatrics. Policy statement-modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics. 2009;124:1694-701.
17. Writzl K, Cale CM, Pierce CM, Wilson LC, Hennekam RCM. Immunological abnormalities in CHARGE syndrome. Eur J Med Genet. 2007;50:338-45.
18. Kobrynski L, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet. 2007;370:1443-52.
19. Litzam J, Jones A, Hann I, Chapel H, Strobel S, Morgan G. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome. Arch Dis Child. 1996;75:436-9.
20. Seger RA. Modern management of chronic granulomatous disease. Brit J Haematol. 2008;140:255-66.
21. Bustamante J, Aksu G, Vogt G, de Beaucoudrey L,Genel F, Chapgier A, et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol. 2007;120:32-8.
22. Goldblatt D. Current treatment options for chronic granulomatous disease. Expert Opin Pharmacother. 2002;3:857-63.
23. Margolis DM, Melnick DA, Alling DW, Gallin J. Trimethoprin-Sulphamethoxazole. Prophylaxis in the management of Chronic Granulomatous Disease. J Infect Dis. 1990;162:723-6.
24. Qasim W, Cavazzana-Calvo M, Davies EG, Davis J, Duval M, Eames G, et al. Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. Pediatrics. 2009;123:836-40.
25. Rosenzweig SD, Holland SM. Phagocyte immunodeficiencies and their infections. J Allergy Clin Immunol. 2004;113:620-6.
26. Al-wahadnech AM, Haddadin I, Hamouri M, Omari K, Aejellat F. Bone marrow transplantation for leukocyte adhesion deficiency-I:Case report. Saudi J Kidney Dis Transplant. 2006;17:564-7.
27. Haverkamp MH, Van Dissel JT, Holland SM. Human host genetic factors in nontuberculous mycobacterial infection:lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-y-dependent signaling. Microbes infect. 2006;8;1157-66.
28. Ward K, Jyonouchi H, Kotenko SV, Smirnov SV, Patel R, Aguila H, et al. Adjuctive treatment of disseminated mycobacterium avium complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency. Eur J Pediatr. 2007;166:981-5.
29. Orange JS, Jain A, Ballas ZK, Schneider LC, Geha RS, Bonilla FA.The presentation and natural history of immunodeficiency caused by nuclear factor kB essential modulator mutation. J Allergy Clin Immunol. 2004;113:725-33.
30. Mancinii AJ, Lawley LP, Uzel G. X-Linked ectodermal dysplasia with immunodeficiency caused by NEMO Mutation. Arch Dermatol. 2008;144:342-6.
31. Cheng LE, Kanwar B, Tcheurekdjian H, Grenert JP, Muskat M, Heyman MB, et al. Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome. Clin Immunol. 2009; 132:124-31.
32. Agarwal R, Tullu MS, Lahiri KR. Importance of life long continuous antimicrobial prophylaxis to prevent infections in patients with Job's syndrome. Arch Med Res. 2004;35:359-60.
33. Freeman AF, Davis J, Anderson VL, Barson W, Darnell DN, Puck JM, et al. Pneumocystis jiroveci infection in patients with HyperImmunoglobulin E Syndrome. Pediatrics (Experience & Reason) 2006;118:1271-5.
34. Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, Anderson V, et al. Causes of death in hyper-IgE syndrome. J Allregy Clin Immunol. 2007;119:1234-40.
35. Davies EG. Update on the management of the immunodeficiency in ataxia-telangiectasia. Expert Rev Clin Immunol. 2009;5:565-75.
36. Anwar GA, Bourke SC, Afolabi G, Middleton P, Ward C, Rutherford RM. Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. Resp Med. 2008;102:1494-6.
37. Davies G, Wilson R. Prophylactic antibiotic treatment of bronchiectasis with azithromycin. Thorax. 2004;59:540-1.
38. Scheinberg P, Shore E. A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis. Chest. 2005;127:1420-6.
39. Hagerman JK, Hancock KE, Klepser ME. Aerolised antibiotics: a critical appraisal of their use. Expert Opin Drug Deliv. 2006;3:71-86.
40. Orange J, Grossman W, Navickis RJ, Wilkes MM. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies. Clin Immunol. 2010;137:21-30.
41. Royal College of Paediatrics and Child Health. Immunisation of the immunocompromised Child. Best Practice Statement [Internet]. London: Royal College of Paediatrics and Child Health; 2002. [Cited 2012 May 18] Available from: http://www.rcpch.ac.uk/ sites/default/files/assetlibrary/Publications/I/Immunocomp.pdf
42. Martin J. Vaccine-derived poliovirus from long term excretors and the end game of polio eradication. Biologicals. 2006;34:117-22.
43. Kondratieva TK, Rubacova EI, Linge IA, Evstifeev VV, Majorov KB, Apt AS. B cells Delay Neutrophil Migration toward the Site of Stimulus: Tardiness critical for effective Bacillus Calmette-Guérin Vaccination against Tuberculosis infection in mice. J Immunol. 2010;184:1227-34.
44. Perez EE, Bokszczanin A, McDonald-McGinn D, Zackai EH, Sullivan KE. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge Syndrome/ Velocardiofacial Syndrome). Pediatrics. 2003;112:325-7.
45. Moylett EH, Wasan AN, Noroski LM, Shearer WT. Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity. Clin Immunol. 2004;112:106-12.
46. th ed. Elk Grove Village, IL;2009. p. 74-6.
47. Tedesco F. Inherited complement deficiencies and bacterial infections. Vaccine. 2008;26S:13-8.
48. Pasic S. Local bacillus Calmette-Guérin infection in hyperimmunoglobulin E syndrome. Acta Paediatr. 2002;91:1271-2.
49. American Academy of Pediatrics. Policy statement-recommendations for the prevention and treatment of influenza in children 2009-2010. Pediatrics. 2009;124:1216-26.
50. CDC. Quadrivalent Human Papillomavirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2007;56 (No RR02);1-24.